Nanomaterials in Personalized Medicine: Global Markets
Report Scope:
The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.
The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.
Report Includes:
The current report will provide detailed exposure to nanomaterials in the personalized medicine market. This report analyzes the market trends of nanomaterials in personalized medicine with data from 2022, estimates from 2023, and projections of compound annual growth rates through 2028 (forecast period of 2023 to 2028. This report will highlight the current and future market potential of nanomaterials in personalized medicine, with a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2028 and the market share for key market players.
The scope of the market in this report is segmented into product type and region. The product type of nanomaterials in personalized medicine is further segmented into proteins, monoclonal antibodies, nanocrystals, liposomes, gold nanoparticles, and quantum dots. The regional market analysis of nanomaterials in personalized medicine is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Detailed analysis of major countries such as the U.S., Germany, the U.K., Italy, France, Japan, China, and India is covered within the regional segments. For market estimates, data is provided for 2022 as the base year, with an estimate for 2023 and forecast value for 2028.
Report Includes:
- 27 data tables and 50 additional tables
- An overview of the global market for nanomaterials in personalized medicine
- Estimates of the market size and analyses of global market trends with data from 2020-2023, and projections of compound annual growth rates (CAGRs) through 2028
- Discussions of the current and future market potential, and quantification of the market by product type and region
- Description of emerging technologies such as biomarkers, deep phenotyping, digital precision medicine, genetics, and health information technology; and discussion on ESG trends and pharma end user sustainability in the industry
- Details about various terms such as monoclonal antibodies (mAbs), nanocrystals, liposomes, their usage in vaccine production, and discussion on how quantum dots work as nanocarriers
- Insights into advances in nanotechnology by using next-generation vaccines regimes and an overview of the government investments in healthcare sectors
- Coverage of projects funded by the National Human Genome Research Institute (NHGRI) and other private and government investments, and information on Sanofi in-licensed Exscientia's innovative bispecific small molecule candidate
- Assessments of innovations and technological advances, the adoption of precision healthcare, and regulatory scenarios, and market drivers, restraints, and opportunities
- Analysis of the market shares of the key companies and their proprietary technologies, patents, partnerships and alliances and other key strategies
- Company profiles of major players within the industry, including Bristol-Myers Squibb, Eisai, Gilead Sciences Inc., and Ipsen Pharma
CHAPTER 1 INTRODUCTION
Overview of Nanotheranostics
Polymeric Nanomaterials
Magnetic Nanomaterials
Silica-Based Nanomaterials
Carbon Nanomaterials
Composite Nanomaterials
Biologic Nanomaterials: Antibody, Proteins and DNA
Carbon Nanotubes
Other Nanomaterials
Multifunctional Nanomaterials
Drug Delivery
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Outlook
Market Insights
CHAPTER 3 MARKET OVERVIEW
Market Overview
Theranostics and Personalized Medicines Overview
Nanoparticles
Passive Targeting
Active Targeting
Nanotechnology Overview
Size Definition
Shape
Surface Area
Nanotheranostic Drug Delivery
In Vivo Drug-Release Studies
Drug Efficacy
Future Perspectives
CHAPTER 4 NANODEVICES AND NANOMATERIALS IN DIAGNOSTICS
Overview
Molecular Recognition in Diagnosis
Nanopatterned Devices
Particles
Carbon Nanotubes
Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials
Cancer Photothermal Therapy
Carbon Nanotubes for Other Therapeutic Applications
Fullerene C60
C60 Toxicity
Uptake and Biodistribution
Antioxidant Properties
Endohedrals
Magnetic Resonance Imaging
Radionuclides
Photodynamic Therapy
DNA Photocleavage
Cancer
Enzymes, Viruses, and Bacteria Inhibition
Drug and Gene Delivery
Magnetic Nanoparticles
Hyperthermia
Magnetic Separation
Imaging and Delivery
Brain Tumor Delivery
Prostate Cancer
Bladder Tumors
Quantum Dots
Aptamer-Conjugated Nanoparticles
Nanoparticle-Based Bio-Bar Codes
Multiplex Dendrimers
Surface Enhanced Raman Spectroscopy
Diagnostic and Medical Device Industry
Multifunctional Nanoparticles
Polymeric Nanoparticles in Cancer Therapy
Polymeric-Based Imaging Probes for Cancer Imaging
Quantum Dots in Cancer Imaging and Therapy
Quantum Dots in Photodynamic Therapy and Imaging
Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy
Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery
Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy
Gold Nanoparticles for Photothermal Therapy
Gold Nanoshells
Gold Nanorods
Magnetic Gold Nanoshells for Photothermal Therapy and Imaging
Conclusion and Future Trends
CHAPTER 5 TREATMENTS BASED ON NANOMATERIAL FOR INFECTIONS ASSOCIATED WITH MEDICAL DEVICES
Infections Associated with Medical Devices and Their Treatments
Catheter-Associated Infections
Soft-Tissue-Implant-Associated Infections
Biofilm Formation
Common Methods for Preventing and Treating Medical Device-Associated Infections
Nanomaterials in Medical Applications
Nanomaterials in Personalized Medicine
Antimicrobial Nanomaterials
Silver Nanoparticles
Zinc Oxide
Iron and Iron-Oxide Nanoparticles
Titanium Oxide
Carbon Nanotubes and Fullerenes
Chitosan
Cytotoxicity Consideration
CHAPTER 6 BIOMEDICAL NANOPARTICLE PRODUCTS
Introduction
Contract Manufacturing Organizations
Information Technology
Nanoparticle Drug Delivery Systems and Products
Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
CHAPTER 7 THERAPEUTIC AND DIAGNOSTIC COMPANION KITS
Introduction
CHAPTER 8 MARKET DYNAMICS
Market Drivers
Rising Prevalence of Chronic Diseases Globally
Rising Cancer Cases Globally
Cancer Mortality
Increasing Number of Diabetes Cases Worldwide
Rising Worldwide Cases of Hypercholesterolemia
Other major drivers in the personalized medicine market are:
Market Restraints
Challenges with Personalized Medicine
Market Opportunities
Nanodrug Delivery for the Treatment of Neurological Disorders
Increasing Government Investment in Healthcare Sectors
Rising Healthcare Costs
Consumer Expectations
CHAPTER 9 REGULATORY LANDSCAPE
Overview
Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts
Regulatory Issues in Nanotechnology
Nanomedicines in the Pharmaceutical Market
Market Access and Pharmacoeconomics
CHAPTER 10 IMPACT OF COVID-19 ON THE MARKET
Overview
Structure of COVID-19 and Penetration
COVID-19 Crisis
Impact of COVID-19 on Nanomaterials in Personalized Medicine
Novel Coronavirus Relying on Various Approaches
Challenges in Vaccine Disruptions
Components and Methods in the Design of a Vaccine
Antigens
Adjuvants
Nanoparticles/Nanocarriers
Devices
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusions Regarding Use of Nanotechnology to Combat COVID-19
COVID-19 Measures
CHAPTER 11 MARKET BREAKDOWN BY PRODUCT TYPE
Market Overview
Proteins
Monoclonal Antibodies (mAbs)
Monoclonal Antibody Therapy
Mechanism
Nanocrystals
Nanocrystals Fabrication
Liposomes
Liposome Classification and Preparation
Sonication
Extrusion
Freeze-Thawed Liposomes
Solvent Dispersion Method
Detergent-Removal Method
Stealth Liposome
Antibody-Liposome Conjugate
Liposome Application in Medicine and Pharmacology
Liposomes in Parasite Diseases and Infections
Liposomes in Anticancer Therapies
In Vitro Optical Imaging
Gold Nanocarrier
Hyperthermia
Contrast Enhancers
Radiotherapy
Quantum Dots as Nanocarriers
Photophysical Properties, Drug-Delivery and Drug-Release Sensing
Visualizing Intracellular Uptake In Vitro
Nanocarrier Biodistribution In Vivo
Short Interfering RNA and DNA delivery
CHAPTER 12 MARKET BREAKDOWN BY REGION
Overview
North America
U.S. Market Size and Forecast
Canada Market Size and Forecast
Europe
Germany Market Size and Forecast
U.K. Market Size and Forecast
France Market Size and Forecast
Italy Market Size and Forecast
Spain Market Size and Forecast
Rest of European Market Size and Forecast
Asia-Pacific
China Market Size and Forecast
Japan Market Size and Forecast
India Market Size and Forecast
South Korea Market Size and Forecast
Rest of Asia-Pacific Market Size and Forecast
Rest of the World
South America Market Size and Forecast
Middle East and Africa Market Size and Forecast
CHAPTER 13 ESG DEVELOPMENT
Introduction to ESG
Environmental
Social
Government
The Sustainability of Major Companies in the Industry
Pharma End User Sustainability in the Industry
Case Study
Concluding Remarks from BCC
CHAPTER 14 EMERGING TECHNOLOGIES
Overview
Current Market Trends
Emerging Technologies
Biomarkers
Deep Phenotyping Technologies
Digital Precision Medicine
Genetics
Health Information Technology
CHAPTER 15 PATENTS AND PIPELINE ANALYSIS
Overview
Patent Analysis
Pipeline Analysis
CHAPTER 16 M&A OUTLOOK
M&A Analysis
Major Strategic Alliances
CHAPTER 17 COMPETITIVE LANDSCAPE
Overview
Distribution of Nanobiotechnology and Nanomedicine Companies
Company Share Analysis
CHAPTER 18 COMPANY PROFILES
BRISTOL-MYERS SQUIBB
CAMURUS AB
CYTIMMUNE SCIENCES
EISAI
GILEAD SCIENCES INC.
IPSEN PHARMA
CHAPTER 19 APPENDIX: ACRONYMS
12. LIST OF TABLES
Summary Table : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
Table A : Types of Nanomaterials
Table B : Major Nanomaterial Applications in Personalized Medicine
Table 1 : Therapies with Diagnostic Companion Kits
Table 2 : Nanoparticle Systems Approved for Drug Delivery
Table 3 : Imaging Modalities Used in Theranostics Nanodevices
Table 4 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 5 : Major Players in Nanoparticle Drug Development and Formulation Market
Table 6 : Nanoparticles Used in Drug Delivery Systems
Table 7 : 12. List of Marketed Products Used in Different Nanotechnology-Based Techniques
Table 8 : Major Companies in the Market for Nanoparticle Drug Development and Formulation
Table 9 : Company Pipelines for Cardiovascular Nanoparticle Drugs
Table 10 : Company Pipelines for CNS Disease Nanoparticle Drugs
Table 11 : Company Pipelines for GI Disease Nanoparticle Drugs
Table 12 : Company Pipelines for Infectious Disease Nanoparticle Drugs
Table 13 : Company Pipelines for Cancer Nanoparticle Drugs
Table 14 : Company Pipelines for Ophthalmic Nanoparticle Drugs
Table 15 : Company Pipelines for Autoimmune Disease Nanoparticle Drugs
Table 16 : Global Prevalence of Breast Cancer, by Country/Region, Through 2025
Table 17 : Global Epidemiology of Colorectal Cancer, by Region, Through 2030
Table 18 : Global Deaths, by Various Cancer Types, Through 2030
Table 19 : Global Death Share, by Various Cancer Types, 2021
Table 20 : Global Diabetes Prevalence, Estimates and Projections, 2019-2045
Table 21 : Cases of Diabetes Worldwide, by Type, 2019
Table 22 : Global Prevalence of Diabetes, by Type, Through 2040
Table 23 : Global Totals of Angina Pectoris and Stroke Survivors, Through 2030
Table 24 : Global Incidence and Prevalence of all Stroke Types, 2019
Table 25 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 26 : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
Table 27 : Products of Non-monoclonal Antibody Proteins
Table 28 : Global Market for Proteins in Personalized Medicine, by Region, Through 2028
Table 29 : Major Companies in the Market for Monoclonal Antibodies
Table 30 : Indications of Monoclonal Antibody Products
Table 31 : Global Market for Monoclonal Antibodies in Personalized Medicine, by Region, Through 2028
Table 32 : Properties of Nanocrystals
Table 33 : Nanocrystal Drug Features
Table 34 : Nanocrystal Fabrication Methods
Table 35 : Nanocrystal Drugs Currently on the Market
Table 36 : Global Market for Nanocrystals in Personalized Medicine, by Region, Through 2028
Table 37 : Liposome Advantages
Table 38 : Liposome-Based Drugs
Table 39 : Major Companies in the Liposomes Market
Table 40 : Global Market for Liposomes in Personalized Medicine, by Region, Through 2028
Table 41 : Global Market for Gold Nanoparticles in Personalized Medicine, Through 2028
Table 42 : Global Market for Quantum Dots in Personalized Medicine, Through 2028
Table 43 : Global Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
Table 44 : Diabetes Estimates in North America, by Country, 2000–2045
Table 45 : Influenza Disease Burden in U.S., by Age Group, 2019 and 2020 Influenza Season
Table 46 : North America Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 47 : Diabetes Estimates in Europe, by Country, 2000–2045
Table 48 : European Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 49 : Tuberculosis Burden of Asian Countries, by Country, 2019
Table 50 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000–2045
Table 51 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 52 : Diabetes Estimates in the RoW, by Country, 2000–2045
Table 53 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 54 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
Table 55 : Key Focus Areas in ESG Metrics
Table 56 : ESG Rankings for Select Nanomaterials Personalized Medicine Companies, 2023
Table 57 : Examples of Nanomaterials Used in Theranostics
Table 58 : Global Patents on Nanotechnologies, by Country, 2017-2020
Table 59 : Number of Patents, by Technology, 2001-2021*
Table 60 : Protein Drugs
Table 61 : Nanoparticle Systems Approved for Drug Delivery
Table 62 : Major Strategic Alliances, 2018–2023
Table 63 : Major Players in the Nanoparticles Drug Field
Table 64 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
Table 65 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
Table 66 : Bristol-Myers Squibb: Key Developments, 2019
Table 67 : Camurus AB: Financial Performance, 2021 and 2022
Table 68 : Camurus AB: Key Developments, 2019
Table 69 : Cytimmune Sciences: News, 2021
Table 70 : Eisai: Financial Performance, 2021 and 2022
Table 71 : Eisai: News, 2021
Table 72 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
Table 73 : Ipsen Pharma: Financial performance, 2021 and 2022
Table 74 : Acronyms Used in This Report
12. LIST OF FIGURES
Figure A : Types of Nanomedicine Composed of Different Types of Materials
Summary Figure : Global Market Shares of Nanomaterials in Personalized Medicine, by Product Type, 2022
Figure 1 : Types of Nanomedicines Composed of Different Types of Materials
Figure 2 : Nanoparticles Used in Personalized Medicine
Figure 3 : Nanotechnology Used in Personalized Medicine
Figure 4 : Shares of New Cancer Cases, Women, 2020
Figure 5 : Shares of New Cancer Cases, Men, 2020
Figure 6 : Global Prevalence of Breast Cancer, by Country/Region, 2015–2025
Figure 7 : Global Epidemiology of Colorectal Cancer, by Region, 2000–2030
Figure 8 : Global Deaths, by Various Cancer Types, 2000–2030
Figure 9 : Global Death Share, by Various Cancer Types, 2021
Figure 10 : Cases of Diabetes Worldwide, by Type, 2019
Figure 11 : Global Prevalence of Diabetes, by Type, 2018 and 2040
Figure 12 : Protein Nanoparticle Fabrication and Performance Factors
Figure 13 : Global Market for Proteins in Personalized Medicine, 2020–2028
Figure 14 : Global Market for Monoclonal Antibodies in Personalized Medicine, 2020–2028
Figure 15 : Global Market for Nanocrystals in Personalized Medicine, 2020–2028
Figure 16 : Application of Liposomes in the Drug Delivery Arena
Figure 17 : Global Market for Liposomes in Personalized Medicine, 2020–2028
Figure 18 : Global Market for Gold Nanoparticles in Personalized Medicine, 2020–2028
Figure 19 : Global Market for Quantum Dots in Personalized Medicine, 2020–2028
Figure 20 : Global Market Shares of Nanomaterials in Personalized Medicine, by Region, 2022
Figure 21 : North America Market for Nanomaterials in Personalized Medicine, by Country, 2020–2028
Figure 22 : Cancer Diagnosis Share in Europe, by Gender, 2020
Figure 23 : European Market for Nanomaterials in Personalized Medicine, by Country, 2020–2028
Figure 24 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, 2020–2028
Figure 25 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, 2020–2028
Figure 26 : How a Strong ESG Proposition Benefits Businesses
Figure 27 : ESG-Adoption Level Across All the Industries, 2021 and 2022
Figure 28 : The Ten Business Sustainability Trends Identified for 2022
Figure 29 : Key Sustainable Practices Being Implemented in Research Laboratories
Figure 30 : Emerging Technologies in the Nanomaterials in Personalized Medicine Market
Figure 31 : Global Market Shares of Nanoparticles in Personalized Medicine, by Company, 2022
Figure 32 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
Figure 33 : Bristol-Myers Squibb: Revenue Share, by Country/Region, 2022
Figure 34 : Camurus AB: Financial Performance, 2021 and 2022
Figure 35 : Camurus AB: Revenue Share, by Country/Region, 2022
Figure 36 : Eisai: Financial Performance, 2021 and 2022
Figure 37 : Eisai: Revenue Share, by Country/Region, 2022
Figure 38 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
Figure 39 : Gilead Sciences Inc.: Revenue Share, by Country/Region, 2022
Figure 40 : Ipsen Pharma: Financial Performance, 2021 and 2022
Figure 41 : Ipsen Pharma: Revenue Share, by Segment, 2022
Figure 42 : Ipsen Pharma: Revenue Share, by Country/Region, 2022
Overview of Nanotheranostics
Polymeric Nanomaterials
Magnetic Nanomaterials
Silica-Based Nanomaterials
Carbon Nanomaterials
Composite Nanomaterials
Biologic Nanomaterials: Antibody, Proteins and DNA
Carbon Nanotubes
Other Nanomaterials
Multifunctional Nanomaterials
Drug Delivery
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
What's New in this Update?
Methodology
Information Sources
Geographic Breakdown
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Market Outlook
Market Insights
CHAPTER 3 MARKET OVERVIEW
Market Overview
Theranostics and Personalized Medicines Overview
Nanoparticles
Passive Targeting
Active Targeting
Nanotechnology Overview
Size Definition
Shape
Surface Area
Nanotheranostic Drug Delivery
In Vivo Drug-Release Studies
Drug Efficacy
Future Perspectives
CHAPTER 4 NANODEVICES AND NANOMATERIALS IN DIAGNOSTICS
Overview
Molecular Recognition in Diagnosis
Nanopatterned Devices
Particles
Carbon Nanotubes
Carbon Nanotubes as a Carriers of Immunoactive Compounds, Proteins and Genetic Materials
Cancer Photothermal Therapy
Carbon Nanotubes for Other Therapeutic Applications
Fullerene C60
C60 Toxicity
Uptake and Biodistribution
Antioxidant Properties
Endohedrals
Magnetic Resonance Imaging
Radionuclides
Photodynamic Therapy
DNA Photocleavage
Cancer
Enzymes, Viruses, and Bacteria Inhibition
Drug and Gene Delivery
Magnetic Nanoparticles
Hyperthermia
Magnetic Separation
Imaging and Delivery
Brain Tumor Delivery
Prostate Cancer
Bladder Tumors
Quantum Dots
Aptamer-Conjugated Nanoparticles
Nanoparticle-Based Bio-Bar Codes
Multiplex Dendrimers
Surface Enhanced Raman Spectroscopy
Diagnostic and Medical Device Industry
Multifunctional Nanoparticles
Polymeric Nanoparticles in Cancer Therapy
Polymeric-Based Imaging Probes for Cancer Imaging
Quantum Dots in Cancer Imaging and Therapy
Quantum Dots in Photodynamic Therapy and Imaging
Multifunctional Imaging Nanoparticles for Cancer Imaging and Therapy
Magnetic Nanoparticles for Magnetic Resonance Imaging and Gene Delivery
Multifunctional Magneto-Polymeric Nanohybrids for Cancer Imaging and Therapy
Gold Nanoparticles for Photothermal Therapy
Gold Nanoshells
Gold Nanorods
Magnetic Gold Nanoshells for Photothermal Therapy and Imaging
Conclusion and Future Trends
CHAPTER 5 TREATMENTS BASED ON NANOMATERIAL FOR INFECTIONS ASSOCIATED WITH MEDICAL DEVICES
Infections Associated with Medical Devices and Their Treatments
Catheter-Associated Infections
Soft-Tissue-Implant-Associated Infections
Biofilm Formation
Common Methods for Preventing and Treating Medical Device-Associated Infections
Nanomaterials in Medical Applications
Nanomaterials in Personalized Medicine
Antimicrobial Nanomaterials
Silver Nanoparticles
Zinc Oxide
Iron and Iron-Oxide Nanoparticles
Titanium Oxide
Carbon Nanotubes and Fullerenes
Chitosan
Cytotoxicity Consideration
CHAPTER 6 BIOMEDICAL NANOPARTICLE PRODUCTS
Introduction
Contract Manufacturing Organizations
Information Technology
Nanoparticle Drug Delivery Systems and Products
Nanoparticle Drug Delivery Systems
Company Pipelines for Nanoparticle Drug Delivery
CHAPTER 7 THERAPEUTIC AND DIAGNOSTIC COMPANION KITS
Introduction
CHAPTER 8 MARKET DYNAMICS
Market Drivers
Rising Prevalence of Chronic Diseases Globally
Rising Cancer Cases Globally
Cancer Mortality
Increasing Number of Diabetes Cases Worldwide
Rising Worldwide Cases of Hypercholesterolemia
Other major drivers in the personalized medicine market are:
Market Restraints
Challenges with Personalized Medicine
Market Opportunities
Nanodrug Delivery for the Treatment of Neurological Disorders
Increasing Government Investment in Healthcare Sectors
Rising Healthcare Costs
Consumer Expectations
CHAPTER 9 REGULATORY LANDSCAPE
Overview
Physicochemical Properties of Nanoproducts Differ Compared to Their Larger Counterparts
Regulatory Issues in Nanotechnology
Nanomedicines in the Pharmaceutical Market
Market Access and Pharmacoeconomics
CHAPTER 10 IMPACT OF COVID-19 ON THE MARKET
Overview
Structure of COVID-19 and Penetration
COVID-19 Crisis
Impact of COVID-19 on Nanomaterials in Personalized Medicine
Novel Coronavirus Relying on Various Approaches
Challenges in Vaccine Disruptions
Components and Methods in the Design of a Vaccine
Antigens
Adjuvants
Nanoparticles/Nanocarriers
Devices
Next-Generation Vaccines Enabled Through Advances in Nanotechnology
Conclusions Regarding Use of Nanotechnology to Combat COVID-19
COVID-19 Measures
CHAPTER 11 MARKET BREAKDOWN BY PRODUCT TYPE
Market Overview
Proteins
Monoclonal Antibodies (mAbs)
Monoclonal Antibody Therapy
Mechanism
Nanocrystals
Nanocrystals Fabrication
Liposomes
Liposome Classification and Preparation
Sonication
Extrusion
Freeze-Thawed Liposomes
Solvent Dispersion Method
Detergent-Removal Method
Stealth Liposome
Antibody-Liposome Conjugate
Liposome Application in Medicine and Pharmacology
Liposomes in Parasite Diseases and Infections
Liposomes in Anticancer Therapies
In Vitro Optical Imaging
Gold Nanocarrier
Hyperthermia
Contrast Enhancers
Radiotherapy
Quantum Dots as Nanocarriers
Photophysical Properties, Drug-Delivery and Drug-Release Sensing
Visualizing Intracellular Uptake In Vitro
Nanocarrier Biodistribution In Vivo
Short Interfering RNA and DNA delivery
CHAPTER 12 MARKET BREAKDOWN BY REGION
Overview
North America
U.S. Market Size and Forecast
Canada Market Size and Forecast
Europe
Germany Market Size and Forecast
U.K. Market Size and Forecast
France Market Size and Forecast
Italy Market Size and Forecast
Spain Market Size and Forecast
Rest of European Market Size and Forecast
Asia-Pacific
China Market Size and Forecast
Japan Market Size and Forecast
India Market Size and Forecast
South Korea Market Size and Forecast
Rest of Asia-Pacific Market Size and Forecast
Rest of the World
South America Market Size and Forecast
Middle East and Africa Market Size and Forecast
CHAPTER 13 ESG DEVELOPMENT
Introduction to ESG
Environmental
Social
Government
The Sustainability of Major Companies in the Industry
Pharma End User Sustainability in the Industry
Case Study
Concluding Remarks from BCC
CHAPTER 14 EMERGING TECHNOLOGIES
Overview
Current Market Trends
Emerging Technologies
Biomarkers
Deep Phenotyping Technologies
Digital Precision Medicine
Genetics
Health Information Technology
CHAPTER 15 PATENTS AND PIPELINE ANALYSIS
Overview
Patent Analysis
Pipeline Analysis
CHAPTER 16 M&A OUTLOOK
M&A Analysis
Major Strategic Alliances
CHAPTER 17 COMPETITIVE LANDSCAPE
Overview
Distribution of Nanobiotechnology and Nanomedicine Companies
Company Share Analysis
CHAPTER 18 COMPANY PROFILES
BRISTOL-MYERS SQUIBB
CAMURUS AB
CYTIMMUNE SCIENCES
EISAI
GILEAD SCIENCES INC.
IPSEN PHARMA
CHAPTER 19 APPENDIX: ACRONYMS
12. LIST OF TABLES
Summary Table : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
Table A : Types of Nanomaterials
Table B : Major Nanomaterial Applications in Personalized Medicine
Table 1 : Therapies with Diagnostic Companion Kits
Table 2 : Nanoparticle Systems Approved for Drug Delivery
Table 3 : Imaging Modalities Used in Theranostics Nanodevices
Table 4 : Nanoparticles Contrast Media Used for In Vivo Diagnostic Imaging
Table 5 : Major Players in Nanoparticle Drug Development and Formulation Market
Table 6 : Nanoparticles Used in Drug Delivery Systems
Table 7 : 12. List of Marketed Products Used in Different Nanotechnology-Based Techniques
Table 8 : Major Companies in the Market for Nanoparticle Drug Development and Formulation
Table 9 : Company Pipelines for Cardiovascular Nanoparticle Drugs
Table 10 : Company Pipelines for CNS Disease Nanoparticle Drugs
Table 11 : Company Pipelines for GI Disease Nanoparticle Drugs
Table 12 : Company Pipelines for Infectious Disease Nanoparticle Drugs
Table 13 : Company Pipelines for Cancer Nanoparticle Drugs
Table 14 : Company Pipelines for Ophthalmic Nanoparticle Drugs
Table 15 : Company Pipelines for Autoimmune Disease Nanoparticle Drugs
Table 16 : Global Prevalence of Breast Cancer, by Country/Region, Through 2025
Table 17 : Global Epidemiology of Colorectal Cancer, by Region, Through 2030
Table 18 : Global Deaths, by Various Cancer Types, Through 2030
Table 19 : Global Death Share, by Various Cancer Types, 2021
Table 20 : Global Diabetes Prevalence, Estimates and Projections, 2019-2045
Table 21 : Cases of Diabetes Worldwide, by Type, 2019
Table 22 : Global Prevalence of Diabetes, by Type, Through 2040
Table 23 : Global Totals of Angina Pectoris and Stroke Survivors, Through 2030
Table 24 : Global Incidence and Prevalence of all Stroke Types, 2019
Table 25 : Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 26 : Global Market for Nanomaterials in Personalized Medicine, by Product Type, Through 2028
Table 27 : Products of Non-monoclonal Antibody Proteins
Table 28 : Global Market for Proteins in Personalized Medicine, by Region, Through 2028
Table 29 : Major Companies in the Market for Monoclonal Antibodies
Table 30 : Indications of Monoclonal Antibody Products
Table 31 : Global Market for Monoclonal Antibodies in Personalized Medicine, by Region, Through 2028
Table 32 : Properties of Nanocrystals
Table 33 : Nanocrystal Drug Features
Table 34 : Nanocrystal Fabrication Methods
Table 35 : Nanocrystal Drugs Currently on the Market
Table 36 : Global Market for Nanocrystals in Personalized Medicine, by Region, Through 2028
Table 37 : Liposome Advantages
Table 38 : Liposome-Based Drugs
Table 39 : Major Companies in the Liposomes Market
Table 40 : Global Market for Liposomes in Personalized Medicine, by Region, Through 2028
Table 41 : Global Market for Gold Nanoparticles in Personalized Medicine, Through 2028
Table 42 : Global Market for Quantum Dots in Personalized Medicine, Through 2028
Table 43 : Global Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
Table 44 : Diabetes Estimates in North America, by Country, 2000–2045
Table 45 : Influenza Disease Burden in U.S., by Age Group, 2019 and 2020 Influenza Season
Table 46 : North America Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 47 : Diabetes Estimates in Europe, by Country, 2000–2045
Table 48 : European Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 49 : Tuberculosis Burden of Asian Countries, by Country, 2019
Table 50 : Diabetes Estimates for the Asia-Pacific Region, by Country, 2000–2045
Table 51 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, Through 2028
Table 52 : Diabetes Estimates in the RoW, by Country, 2000–2045
Table 53 : Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 54 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, Through 2028
Table 55 : Key Focus Areas in ESG Metrics
Table 56 : ESG Rankings for Select Nanomaterials Personalized Medicine Companies, 2023
Table 57 : Examples of Nanomaterials Used in Theranostics
Table 58 : Global Patents on Nanotechnologies, by Country, 2017-2020
Table 59 : Number of Patents, by Technology, 2001-2021*
Table 60 : Protein Drugs
Table 61 : Nanoparticle Systems Approved for Drug Delivery
Table 62 : Major Strategic Alliances, 2018–2023
Table 63 : Major Players in the Nanoparticles Drug Field
Table 64 : Global Distribution of Nanobiotechnology and Nanomedicine Companies
Table 65 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
Table 66 : Bristol-Myers Squibb: Key Developments, 2019
Table 67 : Camurus AB: Financial Performance, 2021 and 2022
Table 68 : Camurus AB: Key Developments, 2019
Table 69 : Cytimmune Sciences: News, 2021
Table 70 : Eisai: Financial Performance, 2021 and 2022
Table 71 : Eisai: News, 2021
Table 72 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
Table 73 : Ipsen Pharma: Financial performance, 2021 and 2022
Table 74 : Acronyms Used in This Report
12. LIST OF FIGURES
Figure A : Types of Nanomedicine Composed of Different Types of Materials
Summary Figure : Global Market Shares of Nanomaterials in Personalized Medicine, by Product Type, 2022
Figure 1 : Types of Nanomedicines Composed of Different Types of Materials
Figure 2 : Nanoparticles Used in Personalized Medicine
Figure 3 : Nanotechnology Used in Personalized Medicine
Figure 4 : Shares of New Cancer Cases, Women, 2020
Figure 5 : Shares of New Cancer Cases, Men, 2020
Figure 6 : Global Prevalence of Breast Cancer, by Country/Region, 2015–2025
Figure 7 : Global Epidemiology of Colorectal Cancer, by Region, 2000–2030
Figure 8 : Global Deaths, by Various Cancer Types, 2000–2030
Figure 9 : Global Death Share, by Various Cancer Types, 2021
Figure 10 : Cases of Diabetes Worldwide, by Type, 2019
Figure 11 : Global Prevalence of Diabetes, by Type, 2018 and 2040
Figure 12 : Protein Nanoparticle Fabrication and Performance Factors
Figure 13 : Global Market for Proteins in Personalized Medicine, 2020–2028
Figure 14 : Global Market for Monoclonal Antibodies in Personalized Medicine, 2020–2028
Figure 15 : Global Market for Nanocrystals in Personalized Medicine, 2020–2028
Figure 16 : Application of Liposomes in the Drug Delivery Arena
Figure 17 : Global Market for Liposomes in Personalized Medicine, 2020–2028
Figure 18 : Global Market for Gold Nanoparticles in Personalized Medicine, 2020–2028
Figure 19 : Global Market for Quantum Dots in Personalized Medicine, 2020–2028
Figure 20 : Global Market Shares of Nanomaterials in Personalized Medicine, by Region, 2022
Figure 21 : North America Market for Nanomaterials in Personalized Medicine, by Country, 2020–2028
Figure 22 : Cancer Diagnosis Share in Europe, by Gender, 2020
Figure 23 : European Market for Nanomaterials in Personalized Medicine, by Country, 2020–2028
Figure 24 : Asia-Pacific Market for Nanomaterials in Personalized Medicine, by Country, 2020–2028
Figure 25 : Rest of the World Market for Nanomaterials in Personalized Medicine, by Region, 2020–2028
Figure 26 : How a Strong ESG Proposition Benefits Businesses
Figure 27 : ESG-Adoption Level Across All the Industries, 2021 and 2022
Figure 28 : The Ten Business Sustainability Trends Identified for 2022
Figure 29 : Key Sustainable Practices Being Implemented in Research Laboratories
Figure 30 : Emerging Technologies in the Nanomaterials in Personalized Medicine Market
Figure 31 : Global Market Shares of Nanoparticles in Personalized Medicine, by Company, 2022
Figure 32 : Bristol-Myers Squibb: Financial Performance, 2021 and 2022
Figure 33 : Bristol-Myers Squibb: Revenue Share, by Country/Region, 2022
Figure 34 : Camurus AB: Financial Performance, 2021 and 2022
Figure 35 : Camurus AB: Revenue Share, by Country/Region, 2022
Figure 36 : Eisai: Financial Performance, 2021 and 2022
Figure 37 : Eisai: Revenue Share, by Country/Region, 2022
Figure 38 : Gilead Sciences Inc.: Financial Performance, 2021 and 2022
Figure 39 : Gilead Sciences Inc.: Revenue Share, by Country/Region, 2022
Figure 40 : Ipsen Pharma: Financial Performance, 2021 and 2022
Figure 41 : Ipsen Pharma: Revenue Share, by Segment, 2022
Figure 42 : Ipsen Pharma: Revenue Share, by Country/Region, 2022
